AeroVironment Earnings Preview: All Eyes On Revenue And Profitability

AeroVironment is heading into a pivotal earnings report with a record $1.1B backlog, but the key focus is gross margin recovery after Q3 margins fell to 24% from BlueHalo mix and supply chain pressures. The stock has already declined 30% YTD and still trades at a post-war premium, while reshoring and BlueHalo integration create ongoing execution and cost risks. Margin normalization will likely determine whether the company can justify current valuation.

Analysis

The key issue is not backlog quality; it is conversion quality. A large order book only helps equity holders if it translates into expanding gross profit dollars, and the current mix suggests the market may be assigning too much value to revenue visibility and too little to margin volatility. If execution on BlueHalo drags the blended margin curve for another 1-2 quarters, the stock can keep de-rating even if bookings stay firm, because defense multiples are typically most sensitive to incremental margin slippage rather than top-line growth.

The second-order risk is that supply-chain reshoring, while strategically defensive, is near-term margin dilutive. Any effort to localize components usually raises working capital, supplier qualification expense, and lead times before it improves resilience, so there is a real possibility that the business enters a lower-return phase right when investors are expecting normalization. That creates a mismatch: a “post-war premium” stock with a long-duration growth narrative can behave like a cyclical industrial if investors conclude margins have structurally reset lower.

What could reverse the move is not another strong backlog headline, but evidence that gross margin inflects meaningfully within the next 1-2 quarters through mix improvement and integration synergies. If management can show that BlueHalo is no longer diluting incremental profit dollars and that supply-chain costs are flattening, the market can quickly re-rate the name because sentiment is already damaged. Absent that, the path of least resistance is still lower as earnings revisions likely dominate backlog optimism.

The contrarian angle is that the selloff may already be discounting too much of the near-term pain if management has genuine visibility into margin recovery later this year. In defense, investors often extrapolate temporary integration noise into a permanent structural issue, and that can create a sharp squeeze if guidance simply confirms stabilization rather than a full rebound. The setup favors trading around the earnings event rather than owning it outright.

Key Decisions for Investors

• Stay tactically short/underweight AVAV into the earnings print; the risk/reward favors downside if gross margin fails to re-accelerate, with the next 1-2 quarters likely to be dominated by revision risk rather than backlog enthusiasm.
• For event-driven accounts, consider a defined-risk put spread on AVAV spanning the next 4-8 weeks; this captures a further de-rating if management trims margin guidance while limiting blow-up risk if the company cites stabilization.
• If seeking a relative-value expression, pair long a higher-quality defense prime or scaled systems name with short AVAV for 1-3 months; the trade isolates execution and integration risk rather than sector beta.
• Only cover/add long exposure on confirmation that gross margin has bottomed and can recover sequentially; absent that signal, the stock likely remains a candidate for multiple compression despite a large backlog.
• If management guides to margin recovery and synergy capture, consider flipping to a short-term tactical long on a post-earnings washout, targeting a 10-15% rebound on multiple re-rating rather than a multi-quarter fundamental thesis.